ALK and McMaster researchers discover new cell that remembers allergies
February 07, 2024 14:10 ET
|
ALK Abello
Researchers with McMaster University and Denmark-based pharmaceutical company ALK-Abelló A/S have made a ground-breaking discovery: a new cell that remembers allergies. The discovery gives...
Societal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug Developers
February 01, 2024 07:00 ET
|
Societal CDMO, Inc.
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing...
Sai Life Sciences augments DMPK capabilities to ace large-scale collaborations
February 01, 2024 04:30 ET
|
SAI LIFE SCIENCES LIMITED
HYDERABAD, India, Feb. 01, 2024 (GLOBE NEWSWIRE) -- To offer global big pharma clients cutting-edge, end-to-end drug metabolism and pharmacokinetics (DMPK) services, Sai Life Sciences, a global...
23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
January 31, 2024 07:30 ET
|
23andMe, Inc.
23ME-01473 (‘1473) seeks to treat cancer by restoring anti-tumor immunity through NK and T cells‘1473 has dual mechanisms of blocking the immunosuppressive effects of soluble ULBP6, and inducing Fc...
Fetal Bovine Serum Market Projected to Reach USD 12.9 Bn at 16.5% CAGR from 2023-2033 | Marketresearch.biz Study
January 29, 2024 02:12 ET
|
MarketResearch.biz
New York, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The fetal bovine serum market was valued at USD 2.9 billion in 2023 with significant growth and is projected to reach USD 12.9 billion by 2033 with an...
Active Pharmaceutical Ingredient Market towards a USD 839.1 Billion by 2033 | Growth driven by advancements in healthcare sector
January 23, 2024 07:47 ET
|
Market.Us
New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Active Pharmaceutical Ingredient market size is forecasted to exceed USD 839.1 Billion by 2033, with a promising CAGR...
Furfural Market to Reach USD 817.9 million by 2031, Registering a CAGR of 5.6%: Exclusive Report by Transparency Market Research, Inc.
January 23, 2024 03:01 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global furfural market is estimated to flourish at a CAGR of 5.6% from 2022 to 2031....
Elevar Therapeutics To Present Two Posters From Phase 3 CARES-310 Study at 2024 ASCO Gastrointestinal Cancers Symposium
January 18, 2024 08:45 ET
|
Elevar Therapeutics
A post hoc analysis found the efficacy of camrelizumab plus rivoceranib was superior to sorafenib regardless of baseline liver function as measured by both albumin-bilirubin grade and Child-Pugh...
Phenoxyethanol Market to Reach USD 329.4 million by 2031, Expanding at a CAGR of 5.1% from 2023 to 2031: Transparency Market Research, Inc.
January 16, 2024 05:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global phenoxyethanol market is estimated to flourish at a CAGR of 5.1% from 2023 to...
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
January 10, 2024 19:30 ET
|
Sermonix Pharmaceuticals Inc.
Partnership expands Henlius’ portfolio with license of exclusive China rights to develop, manufacture and commercialize lasofoxifene; Sermonix retains all other global rightsHenlius to facilitate...